Hear insights from a Patient Engagement Specialist on enrolling patients into a remote diabetes program.

Learn how Emma improved her diabetes outcomes alongside a SweetSpot CDCES.

This blog discusses how continuous data monitoring can enhance care for people with type 1 diabetes.

Discover how DGD Clinic successfully launched a remote diabetes monitoring program.

Learn how Jenny gained confidence with her diabetes technology through SweetSpot.

Ongoing CGM monitoring and data analysis can help you identify patterns, guide treatment, and prevent hypoglycemia — especially in high-risk patients.

With trusted support between visits, Amanda cut her GRI by more than half and reclaimed her energy — showing what’s possible when patients feel heard.

Why practices are turning to SweetSpot to scale diabetes care without financial risk.

We’ll explore how regular reviews of CGM and insulin pump data — combined with timely clinical interventions — can help you keep your patients healthier and out of the hospital.

How one 20-minute phone call through SweetSpot’s remote monitoring program helped a patient cut hypoglycemia by 80% — and feel more confident managing her diabetes.

Here's 5 key takeaways from our webinar on the impact of the Glycemia Risk Index

Here's 3 reasons why regular CGM data reviews help prevent heart complications for people with diabetes.

This blog includes a video recap of our webinar on remote CGM monitoring.

Here's a recap of some of the most insightful questions and responses from our recent webinar on remote CGM monitoring.

SweetSpot’s new integration with Eversense 365 enables seamless, real-time CGM monitoring.

This blog discusses how continuous data monitoring can enhance care for every type of diabetes.

This blog dives into whether a remote CGM monitoring program is right for your practice.

This blog outlines solutions to skin irritation issues associated with CGM wearing.

This blog discusses how SweetSpot impacted an endocrinology practice in Missouri.

This blog details the impact of GLP-1 therapy on patients using insulin pumps and best practices in their diabetes management.